![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Recordati Industria Chimica E Farmaceutica S.p.a. Milano It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Mebeverine hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-002 - Rev 00
This Chemical Type CEP, issued on March 13, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2097 associated with this CEP further emphasizes